Sort
30,917 grants matching “tumor microenvironment”
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$851,913James M Olson · Seattle Children'S Hospital · U01 · FY2025 · CA
Improving risk allocation and developing novel therapies for children with T-ALL and T-LL
$851,561David T. Teachey · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$850,957Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2022 · CA
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$850,188Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA
Engineering Effective T cell Immunity to Multiple Myeloma
$850,024Stanley R Riddell · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Engineering Effective T cell Immunity to Multiple Myeloma
$850,024Stanley R Riddell · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Application of RiboTag-seq to Exploration of Tumor Microenvironments
$850,000David R Morris · University Of Washington · RC2 · FY2009 · CA
Astrocytic Cancers: How, When, Where?
$850,000University Of North Carolina Chapel Hill · U01 · FY2004 · CA
Growth Control in Multiple Myeloma
$849,984Bart Barlogie · Univ Of Arkansas For Med Scis · P01 · FY2009 · CA
Core Support for Cancer Center
$849,449Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2010 · CA
Molecular pathways and targeted therapies in human leukemia
$849,333Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2017 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$849,297Ronald Levy · Stanford University · R35 · FY2021 · CA
Development of TGF-beta antagonists for cancer therapy
$848,658Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
The Role of Inflammation and Stroma in Digestive Cancer
$848,610Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2010 · CA
FUNCTIONAL AND MOLECULAR DIVERSITY IN THE TUMOR MICROENVIRONMENT UNDERLIES THERAPEUTIC RESPONSE AND RESISTANCE
$848,420University Of Wisconsin System · · FY2016 · Department of the Army
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$848,343David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2020 · CA
TARGETING SCHWANN CELL-TUMOR MICROENVIRONMENT INTERACTIONS IN NEUROFIBROMA DEVELOPMENT
$847,875Rector & Visitors Of The University Of Virginia · · FY2025 · Defense Health Agency
Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging
$847,774Eric Kaldjian · Rarecyte, Inc. · R44 · FY2021 · CA
Preclinical Development of a Novel and Powerful Immunotherapeutic
$847,617Susan Dana Jones · Immurx Llc · R44 · FY2012 · AI
Angiogenesis and Tumor Growth
$847,609Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$847,050Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Vaccine and radiation for the therapy of human cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Elucidating the role of tissue biophysics in organ colonization
$846,863Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Signal Transduction Events and the Regulation of Cell Growth
$846,744Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Clinical trials employing cancer vaccine combination therapies
$846,484James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA